Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Trends Cancer. 2018 Jan 12;4(2):101–109. doi: 10.1016/j.trecan.2017.12.004

Figure 2. Six blind men and elephants.

Figure 2

Beyond genomics—transcriptomics, proteomics and more: The comprehensive molecular profile of the not-too-distant future may include genomics, transcriptomics, proteomics, metabolomics, microbiomics epigenomics, mutanomics, lipidomics, and immunogenotyping, and may hence predict response to multiple modalities including immunotherapy and chemotherapy [47–56]. Each of these modalities gives us a piece of the puzzle, akin to the parable of the six blind men who each touch a different part of the elephant, such as the tusk versus the trunk, and therefore have vastly different views of the elephant. “Panomics” testing is a requisite of comprehensive analysis and may require complex computer algorithms for data integration and computation.